These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19906645)

  • 1. Role of interfacial water molecules in proline-rich ligand recognition by the Src homology 3 domain of Abl.
    Palencia A; Camara-Artigas A; Pisabarro MT; Martinez JC; Luque I
    J Biol Chem; 2010 Jan; 285(4):2823-33. PubMed ID: 19906645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermodynamic dissection of the binding energetics of proline-rich peptides to the Abl-SH3 domain: implications for rational ligand design.
    Palencia A; Cobos ES; Mateo PL; Martínez JC; Luque I
    J Mol Biol; 2004 Feb; 336(2):527-37. PubMed ID: 14757063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The high-resolution NMR structure of the R21A Spc-SH3:P41 complex: understanding the determinants of binding affinity by comparison with Abl-SH3.
    Casares S; Ab E; Eshuis H; Lopez-Mayorga O; van Nuland NA; Conejero-Lara F
    BMC Struct Biol; 2007 Apr; 7():22. PubMed ID: 17407569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
    Pisabarro MT; Serrano L; Wilmanns M
    J Mol Biol; 1998 Aug; 281(3):513-21. PubMed ID: 9698566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the thermodynamics of binding of an SH3 domain to proline-rich peptides using a chimeric fusion protein.
    Candel AM; van Nuland NA; Martin-Sierra FM; Martinez JC; Conejero-Lara F
    J Mol Biol; 2008 Mar; 377(1):117-35. PubMed ID: 18234212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interfacial water molecules in SH3 interactions: Getting the full picture on polyproline recognition by protein-protein interaction domains.
    Zafra-Ruano A; Luque I
    FEBS Lett; 2012 Aug; 586(17):2619-30. PubMed ID: 22584053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proline-rich sequences that bind to Src homology 3 domains with individual specificities.
    Alexandropoulos K; Cheng G; Baltimore D
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3110-4. PubMed ID: 7536925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interfacial water molecules in SH3 interactions: a revised paradigm for polyproline recognition.
    Martin-Garcia JM; Ruiz-Sanz J; Luque I
    Biochem J; 2012 Mar; 442(2):443-51. PubMed ID: 22115123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A binding event converted into a folding event.
    Martín-Sierra FM; Candel AM; Casares S; Filimonov VV; Martínez JC; Conejero-Lara F
    FEBS Lett; 2003 Oct; 553(3):328-32. PubMed ID: 14572645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding Mechanism of the N-Terminal SH3 Domain of CrkII and Proline-Rich Motifs in cAbl.
    Bhatt VS; Zeng D; Krieger I; Sacchettini JC; Cho JH
    Biophys J; 2016 Jun; 110(12):2630-2641. PubMed ID: 27332121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-state dynamics of the SH3-SH2 tandem of Abl kinase and the allosteric role of the N-cap.
    Corbi-Verge C; Marinelli F; Zafra-Ruano A; Ruiz-Sanz J; Luque I; Faraldo-Gómez JD
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):E3372-80. PubMed ID: 23959873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution crystal structures of tyrosine kinase SH3 domains complexed with proline-rich peptides.
    Musacchio A; Saraste M; Wilmanns M
    Nat Struct Biol; 1994 Aug; 1(8):546-51. PubMed ID: 7664083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
    Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
    Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2.
    Sparks AB; Rider JE; Hoffman NG; Fowlkes DM; Quillam LA; Kay BK
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1540-4. PubMed ID: 8643668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function analysis of SH3 domains: SH3 binding specificity altered by single amino acid substitutions.
    Weng Z; Rickles RJ; Feng S; Richard S; Shaw AS; Schreiber SL; Brugge JS
    Mol Cell Biol; 1995 Oct; 15(10):5627-34. PubMed ID: 7565714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design of specific high-affinity peptide ligands for the Abl-SH3 domain.
    Pisabarro MT; Serrano L
    Biochemistry; 1996 Aug; 35(33):10634-40. PubMed ID: 8718852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into the tyrosine phosphorylation-mediated inhibition of SH3 domain-ligand interactions.
    Merő B; Radnai L; Gógl G; Tőke O; Leveles I; Koprivanacz K; Szeder B; Dülk M; Kudlik G; Vas V; Cserkaszky A; Sipeki S; Nyitray L; Vértessy BG; Buday L
    J Biol Chem; 2019 Mar; 294(12):4608-4620. PubMed ID: 30659095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reexamination of the recognition preference of the specificity pocket of the Abl SH3 domain.
    Santamaria F; Wu Z; Boulègue C; Pál G; Lu W
    J Mol Recognit; 2003; 16(3):131-8. PubMed ID: 12833568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational analysis and prediction of the binding motif and protein interacting partners of the Abl SH3 domain.
    Hou T; Chen K; McLaughlin WA; Lu B; Wang W
    PLoS Comput Biol; 2006 Jan; 2(1):e1. PubMed ID: 16446784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.